{"component": "definition", "props": {"groups": [{"samples": [{"hash": "1VWIc7BdztW", "uri": "https://www.scstatehouse.gov/sess125_2023-2024/prever/3592_20240227.docx", "label": "Amendment", "score": 20.7312469482, "published": false}, {"hash": "gB3x3BVAHGR", "uri": "https://www.scstatehouse.gov/sess125_2023-2024/prever/3592_20240119.docx", "label": "www.scstatehouse.gov", "score": 16.6783046722, "published": false}, {"hash": "8eckXCnv69Y", "uri": "https://www.scstatehouse.gov/sess125_2023-2024/prever/3592_20240118.docx", "label": "www.scstatehouse.gov", "score": 16.6671504974, "published": false}], "snippet": "means a sterile preparation of drugs for injection through one or more layers of the skin.", "snippet_links": [{"key": "preparation-of", "type": "clause", "offset": [16, 30]}], "size": 47, "hash": "e863d153126c0117221399383a24d4e5", "id": 1}, {"samples": [{"hash": "yDmVnmvCko", "uri": "https://dopl.utah.gov/wp-content/uploads/2024/11/R156-17b.-Pharmacy-Practice-Act-Rule-published-in-the-Utah-State-Bulletin-November-15-2024-Vol.-2024-No.-22.pdf", "label": "dopl.utah.gov", "score": 19.5874519348, "published": false}, {"hash": "iOmDc8mxQa2", "uri": "https://www.utah.gov/pmn/files/1174315.pdf", "label": "www.utah.gov", "score": 17.4228782654, "published": false}, {"hash": "kin1AFyuK9", "uri": "https://rules.utah.gov/wp-content/uploads/b20201001.pdf", "label": "rules.utah.gov", "score": 15.5150098801, "published": false}], "snippet": "means a method of drug delivery injected into body tissues but not via the gastrointestinal tract.", "snippet_links": [{"key": "method-of", "type": "clause", "offset": [8, 17]}], "size": 45, "hash": "f6d5f18fd4b8ac26afa0a7893337a317", "id": 2}, {"samples": [{"hash": "k6vIoUGhAtr", "uri": "https://www.mbp.ms.gov/sites/default/files/2025-05/REGULATIONS.pdf", "label": "www.mbp.ms.gov", "score": 16.8727830273, "published": false}, {"hash": "d0JR0MCtz2d", "uri": "https://www.mbp.ms.gov/sites/default/files/2024-11/REGULATIONS.pdf", "label": "www.mbp.ms.gov", "score": 16.6020717621, "published": false}, {"hash": "2IfHNFHysKD", "uri": "https://www.mbp.ms.gov/sites/default/files/2024-04/REGULATIONS.pdf", "label": "www.mbp.ms.gov", "score": 12.1444215775, "published": false}], "snippet": "means sterile preparations of drugs for injection through one or more layers of skin.", "snippet_links": [], "size": 29, "hash": "4c96618462d748c0e1155d445d8eba43", "id": 3}, {"samples": [{"hash": "gee26c5IIqa", "uri": "https://www.msdssafety.com/wp-content/uploads/2018/05/Dental-Board-of-Virginia-Copied-forms.docx", "label": "Note", "score": 13.0328540802, "published": false}, {"hash": "8doFNDY1AIc", "uri": "https://www.dhp.virginia.gov/Dentistry/leg/DentalHygiene10152020.docx", "label": "www.dhp.virginia.gov", "score": 10.6344966888, "published": false}, {"hash": "21pJ4PrwF9a", "uri": "https://www.dhp.virginia.gov/dentistry/leg/Dentistry031721.docx", "label": "www.dhp.virginia.gov", "score": 10.6057491302, "published": false}], "snippet": "means a technique of administration in which the drug bypasses the gastrointestinal tract (i.e., intramuscular, intravenous, intranasal, submucosal, subcutaneous, or intraocular).", "snippet_links": [], "size": 17, "hash": "779b44b564c4a9a18d26f86f2335e009", "id": 4}, {"samples": [{"hash": "l5bmk6Vc8sz", "uri": "https://oklahoma.gov/content/dam/ok/en/odmhsas/documents/policy/provider-certification/administrative-rules/2024/PC--Chapter-70_10-30-24.pdf", "label": "oklahoma.gov", "score": 18.5417003632, "published": false}, {"hash": "7vdZdRVvgJZ", "uri": "https://oklahoma.gov/content/dam/ok/en/odmhsas/documents/policy/provider-certification/administrative-rules/2023/PC--Chapter-70-Final-effective-9-15-23.pdf", "label": "oklahoma.gov", "score": 10.826830864, "published": false}, {"hash": "eZpYTQK5oJH", "uri": "https://oklahoma.gov/content/dam/ok/en/odmhsas/documents/policy/provider-certification/administrative-rules/2022/Chapter%2070%20Final%20effective%209-15-22%20w%20History.pdf", "label": "oklahoma.gov", "score": 10.3490762711, "published": false}], "snippet": "means injected, infused or implanted, used to describe drug administration other than oral or anal.", "snippet_links": [{"key": "drug-administration", "type": "definition", "offset": [55, 74]}], "size": 10, "hash": "977d1feb14451c9a556be1da8870deaf", "id": 5}, {"samples": [{"hash": "jKpw8TrvoqV", "uri": "https://wyoleg.gov/ARules/2012/Rules/ARR17-018P.pdf", "label": "Notice", "score": 12.4277887344, "published": false}, {"hash": "1XJAQ6tGHSx", "uri": "https://wyoleg.gov/ARules/2012/Rules/ARR14-034P.pdf", "label": "Notice", "score": 11.3955202103, "published": false}, {"hash": "3aDvb1iy9Pf", "uri": "https://wyoleg.gov/ARules/2012/Rules/ARR17-018.pdf", "label": "wyoleg.gov", "score": 8.7946615219, "published": false}], "snippet": "means a route of administration in which the drug bypasses the gastrointestinal tract [i.e., intramuscular, intravenous, intranasal, submucosal, subcutaneous, or intraosseous].", "snippet_links": [{"key": "route-of-administration", "type": "definition", "offset": [8, 31]}], "size": 9, "hash": "c5d251159417463ae30749673b7e52eb", "id": 6}, {"samples": [{"hash": "hZFj4Mcdjky", "uri": "https://www.scstatehouse.gov/sess120_2013-2014/sj14/20140401.htm", "label": "www.scstatehouse.gov", "score": 10.1704311371, "published": false}, {"hash": "4758YtmSOPT", "uri": "https://www.scstatehouse.gov/sess124_2021-2022/bills/4085.docx", "label": "www.scstatehouse.gov", "score": 8.6043806076, "published": false}, {"hash": "12DdYEeUCSI", "uri": "https://www.scstatehouse.gov/sess124_2021-2022/prever/4085_20210317.docx", "label": "www.scstatehouse.gov", "score": 8.603012085, "published": false}], "snippet": "means a route of administration in which the drug bypasses the gastrointestinal tract.", "snippet_links": [{"key": "route-of-administration", "type": "definition", "offset": [8, 31]}], "size": 8, "hash": "b0d6c20b37feaba76364f9ee00077226", "id": 7}, {"samples": [{"hash": "kRHAHn7vQVw", "uri": "https://www.michigan.gov/lara/-/media/Project/Websites/lara/bpl/Dentistry/Rules-Work-Group--Agenda-Minutes-Notices/10-10-22-Dentistry-Rules-Work-Group-minutes-with-attachment.pdf?rev=705af1d582b44e98a4656359f68124c7&hash=AE4C229A5E56558984192C7729858C2D", "label": "www.michigan.gov", "score": 11.3887748718, "published": false}, {"hash": "idV28ZSxDBG", "uri": "https://www.michigan.gov/lara/-/media/Project/Websites/lara/bpl/Dentistry/Board-Agendas-and-Minutes/10-13-22-Dentistry-Full-Approved-minutes.pdf?rev=81e675c61b0b4f29bc36d8a2e48e105c&hash=4CDA0BFA674B4EC6732480BF2F0F6B39", "label": "www.michigan.gov", "score": 11.3887748718, "published": false}, {"hash": "an2g8riOMxi", "uri": "https://www.michigan.gov/lara/-/media/Project/Websites/lara/bpl/Dentistry/Rules-Work-Group--Agenda-Minutes-Notices/10-7-22-Dentistry-Rules-Work-Group-minutes-wi9th-attachment.pdf?rev=fdb0be87e91b4405a9d58c667577ef6b&hash=D51511FB38695FD4EBCBCF9CC74B54E1", "label": "www.michigan.gov", "score": 11.3860368729, "published": false}], "snippet": "means a technique of administration in which the drug bypasses the gastrointestinal (gi) tract, including intramuscular (im), intravenous (iv), intranasal (in), submucosal (sm), subcutaneous (sc), and intraocular (io).", "snippet_links": [], "size": 8, "hash": "2dd8dce8805a6dd7f36c4f024e0687d1", "id": 8}, {"samples": [{"hash": "dd3PcI3WGDi", "uri": "https://lawfilesext.leg.wa.gov/law/wsrpdf/2024/01/24-01-033.pdf", "label": "lawfilesext.leg.wa.gov", "score": 18.9185562134, "published": false}, {"hash": "btvBXaa4ldp", "uri": "https://lawfilesext.leg.wa.gov/law/WSRPDF/2022/23/22-23-076.pdf", "label": "lawfilesext.leg.wa.gov", "score": 17.7993373871, "published": false}, {"hash": "hlDCBziBJYo", "uri": "https://app.leg.wa.gov/documents/laws/WSRPDF/2023/16/23-16-108.pdf", "label": "app.leg.wa.gov", "score": 11.802189827, "published": false}], "snippet": "means a technique of administration in which the drug bypasses the gastrointestinal (GI) tract (((i.e.)) including, but not limited to, intramuscular, intravenous, intranasal, submuscos- al, subcutaneous, and intraosseous(())).", "snippet_links": [{"key": "not-limited", "type": "clause", "offset": [120, 131]}], "size": 7, "hash": "1bcb80d488561277183eefbab96a0859", "id": 9}, {"samples": [{"hash": "hUWT7oMLu1", "uri": "https://www.rld.nm.gov/uploads/files/Complete%20Rules%20and%20Statutes%20Effective%2012-14-19(1).pdf", "label": "www.rld.nm.gov", "score": 10.0075292587, "published": false}, {"hash": "csVueBvKJu7", "uri": "http://www.rld.state.nm.us/uploads/files/Complete%20Rules%20and%20Statutes%20Effective%2012-14-19.pdf", "label": "www.rld.state.nm.us", "score": 10.0075292587, "published": false}, {"hash": "h2qLcAH08M2", "uri": "http://www.rld.state.nm.us/uploads/files/Complete%20Rules%20and%20Statutes%203-18-18(6).pdf", "label": "www.rld.state.nm.us", "score": 9.3107461929, "published": false}], "snippet": "means any technique of administration in which the drug is injected through the dermis or into blood vessel (i.e.,; intramuscular, subcutaneous, or intravenous injections).", "snippet_links": [], "size": 6, "hash": "e1b824332fb8821dab30571c4dde2dbe", "id": 10}], "next_curs": "ClcSUWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjMLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiITcGFyZW50ZXJhbCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means a sterile preparation of drugs for injection through one or more layers of the skin.", "title": "Parenteral", "size": 285, "id": "parenteral", "examples": ["Total <strong>Parenteral</strong> Nutrition (TPN) is the administration of nutrients through intravenous catheters via central or peripheral veins and is Covered when ordered by an In-network Practitioner/Provider.", "<strong>Parenteral</strong> Nutrition/Supplies X Necessary supplies (e.g., tubing, filters, connectors, etc.) are eligible for coverage when the Health Plan has authorized the <strong>parenteral</strong> nutrition.", "Total <strong>Parenteral</strong> Nutrition (TPN) is the administration of nutrients through intravenous catheters via central or peripheral veins and is Covered when ordered by a Practitioner/Provider.", "Benefits include: \u2022 Home infusion agency Skilled Nursing visits; \u2022 Infusion therapy provided in an infusion suite associated with a Participating home infusion agency; \u2022 <strong>Parenteral</strong> nutrition services and associated supplies and solutions; \u2022 Enteral nutrition services and associated supplies and solutions; \u2022 Medical supplies used during a covered visit; and \u2022 Medications injected or administered intravenously.", "Benefits include: \uf0b7 Home infusion agency Skilled Nursing visits; \uf0b7 Infusion therapy provided in an infusion suite associated with a Participating home infusion agency; \uf0b7 <strong>Parenteral</strong> nutrition services and associated supplies and solutions; \uf0b7 Enteral nutrition services and associated supplies and solutions; \uf0b7 Medical supplies used during a covered visit; and \uf0b7 Medications injected or administered intravenously.", "APIL shall be responsible for procuring all components and materials, including active pharmaceutical ingredient (API), required to prepare, manufacture, test, store and supply BC <strong>Parenteral</strong> Meloxicam and Finished Meloxicam, prior to final clinical or commercial labeling and packaging, for commercial and clinical use; provided, that, in the case of clinical use of Finished Meloxicam only, APIL shall supply finished product prior to labeling.", "Subject to the terms and conditions of this Agreement, effective the Effective Date, APIL hereby grants Purchaser an exclusive, worldwide license under the Nanotechnology IP, with the right to sublicense, to develop, make, have made, use, sell, offer to sell and import Meloxicam IV/IM and Meloxicam <strong>Parenteral</strong> Formulation for the treatment of any human disease, disorder or condition, subject to the Merck Agreement.", "Recro Sub shall pay APIL [***] for (i) Finished Meloxicam supplied by APIL for clinical use prior to FDA approval and (ii) BC <strong>Parenteral</strong> Meloxicam supplied by APIL for clinical use prior to FDA approval.", "APIL shall supply BC <strong>Parenteral</strong> Meloxicam exclusively to Recro Sub (and its affiliates, licensees and/or distributors) and shall not supply BC <strong>Parenteral</strong> Meloxicam to any other person.", "Recro Sub shall be responsible for product labeling and distribution to clinical sites or commercial distribution for BC <strong>Parenteral</strong> Meloxicam and Finished Meloxicam."], "related": [["enteral", "Enteral", "Enteral"], ["prosthesis", "Prosthesis", "Prosthesis"], ["brachytherapy", "Brachytherapy", "Brachytherapy"], ["halogen", "Halogen", "Halogen"], ["cannabidiol", "Cannabidiol", "Cannabidiol"]], "related_snippets": [], "updated": "2025-07-10T05:58:13+00:00"}, "json": true, "cursor": ""}}